ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer.

Ramadhan KarsonoSamuel J HaryonoBambang KarsonoWirsma Arif HarahapYulia PratiwiTeguh Aryandono

Published in: BMC cancer (2021)

The ESR1 PvuII TC + CC genotypes confer poor prognosis in advanced breast cancer, but these genotypes could be regarded as a good predictor of the therapeutic effect of hormonal treatment.

Keyphrases

poor prognosis
long non coding rna
estrogen receptor
risk factors
stem cells
type diabetes
mesenchymal stem cells
polycystic ovary syndrome
insulin resistance